Evaluation of hypertension-related complications 10 years after implementation of risk assessment and management programme for hypertension: a target trial emulation - Top-Institutions - MDSpire

Evaluation of hypertension-related complications 10 years after implementation of risk assessment and management programme for hypertension: a target trial emulation

  • By

  • Zoey Cho Ting Wong

  • Ivy Lynn Mak

  • Esther Yee Tak Yu

  • Emily Tsui Yee Tse

  • Julie Yun Chen

  • Weng Yee Chin

  • David Vai Kiong Chao

  • Wendy Wing Sze Tsui

  • Tony King Hang Ha

  • Eric Yuk Fai Wan

  • Cindy Lo Kuen Lam

  • August 4, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Hypertension
    • Epidemiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Hypertension
    • Primary Care

  • #3

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Cardiology
    • Hypertension
    • Clinical Research

  • #4

    University of Oxford
    University of Oxford

    Oxford, Oxfordshire

    Key Differentiators

    • Cardiology
    • Hypertension
    • Epidemiology

  • #5

    National University of Singapore (NUS)
    National University of Singapore (NUS)

    Singapore, Singapore

    Key Differentiators

    • Cardiology
    • Hypertension
    • Public Health

Original Source(s)

Evaluation of hypertension-related complications 10 years after implementation of risk assessment and management programme for hypertension: a target trial emulation

  • by Zoey Cho Ting Wong, Ivy Lynn Mak, Esther Yee Tak Yu, Emily Tsui Yee Tse, Julie Yun Chen, Weng Yee Chin, David Vai Kiong Chao, Wendy Wing Sze Tsui, Tony King Hang Ha, Eric Yuk Fai Wan, Cindy Lo Kuen Lam

  • August 4, 2025

Related Content

How Quickly Are Patients Reaching Quadruple HFrEF Therapy?

Delays in initiating guideline-directed quadruple therapy may increase early clinical risk in heart failure with reduced ejection fraction.

Gut dysbiosis and systemic inflammation in elderly hypertensive patients with amnestic mild cognitive impairment

Optimizing Food-Is-Medicine Programs for High Blood Pressure